Our research provides novel insights into CDH17 analysis in CRC through a complex assessment targeting the tumor core, invasive front, tumor emboli, and lymph node metastasis, as well as their relationship with a large panel of clinicopathological and survival characteristics. Here, CDH17 is linked to colorectal carcinoma.